ENHANCED TRANSGENE EXPRESSION IN UROTHELIAL CANCER GENE THERAPY WITH HISTONE DEACETYLASE INHIBITOR
- 1 August 2005
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 174 (2) , 747-752
- https://doi.org/10.1097/01.ju.0000164723.20555.e6
Abstract
Purpose: Efficient adenoviral infection requires the presence of the coxsackievirus and adenovirus receptor (CAR). We determined whether the histone deacetylase inhibitor FR901228 (Fujisawa...Keywords
This publication has 10 references indexed in Scilit:
- Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cellsCancer Gene Therapy, 2004
- Impact of novel histone deacetylase inhibitors, CHAP31 and FR901228(FK228), on adenovirus-mediated transgene expressionThe Journal of Gene Medicine, 2004
- Integrin αv and coxsackie adenovirus receptor expression in clinical bladder cancerUrology, 2002
- Histone-deacetylase inhibitors: novel drugs for the treatment of cancerNature Reviews Drug Discovery, 2002
- Histone deacetylase inhibitor FR901228 enhances adenovirus infection of hematopoietic cellsBlood, 2002
- Bladder CancerEuropean Urology, 2001
- THE GROWTH INHIBITORY EFFECT OF p21 ADENOVIRUS ON HUMAN BLADDER CANCER CELLSJournal of Urology, 2000
- LOSS OF ADENOVIRAL RECEPTOR EXPRESSION IN HUMAN BLADDER CANCER CELLS- A POTENTIAL IMPACT ON THE EFFICACY OF GENE THERAPYJournal of Urology, 1999
- Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5Science, 1997
- Fibroblast-mediated acceleration of human epithelial tumor growth in vivo.Proceedings of the National Academy of Sciences, 1990